Thyme Care

Value-based cancer care navigation: remote oncology nurse navigators and social workers. Founded 2020, Nashville. ~$400M raised at a $2B+ valuation. Rates published, ~$39-46/hr, US licensure required.

Services Value-Based Oncology / Cancer Care Navigation
Visit Thyme Care
★ ★ ★ ★ ★ New (0 reviews)
Nashville, TN, USA (clinical roles remote, US-only, Eastern-time shifts) HQ
400 employees
2020 founded

What is Thyme Care?

Thyme Care is a value-based oncology company providing cancer care navigation, combining human support with technology. Its nurse navigators, social workers, and care partners guide people through a cancer diagnosis, handling triage, symptom management, education, transitions of care, and psychosocial support, working alongside oncologists, health plans, and health systems under value-based contracts rather than fee-for-service billing. The company was founded in 2020, is headquartered in Nashville, Tennessee, and employs around 400 people. It reports that its services are available to more than 10.5 million people across all 50 US states, that it has supported over 270,000 people, and that it manages more than $7 billion in oncology spend. Its leadership changed recently: co-founder Robin Shah stepped down as chief executive in July 2026 to become Executive Chairman of Thyme Companies, a platform for further oncology ventures, and Brad Diephuis, previously President and Chief Operating Officer, took over as CEO. Co-founder Bobby Green serves as Chief Medical Officer. On funding, two recent rounds are easily confused. In September 2025 it raised a $97 million Series D backed by CVS Health Ventures, Humana, Morgan Health, Texas Oncology and Memorial Hermann alongside existing investors including a16z Bio + Health, Foresite Capital, Town Hall Ventures and AlleyCorp, which brought its total to $275 million, pushed its valuation past $1 billion, and came as the company reported reaching profitability. Then in September 2026 it raised a further $125 million at a valuation above $2 billion, taking the total raised to roughly $400 million. Sources citing $275 million raised or a valuation above $1 billion are describing the 2025 position rather than the current one.

Mission & values

Give everyone facing cancer a navigator in their corner, and align the economics of oncology around better outcomes rather than volume of treatment.

Qualifications

Thyme Care is one of the better remote employers on this board for licensed clinicians, and unusually it publishes rates on its listings. Observed remote roles include Oncology Nurse Navigator at $39.90 per hour, Oncology Transitions of Care Nurse at $45.67 per hour, Oncology Nurse Team Lead at around $104,000, and Social Work Team Lead at around $105,000. The navigator role involves acting as a clinical resource for members and their families, delivering triage, support, and education throughout the cancer journey by phone, email, and video, and conducting comprehensive clinical assessments under the guidance of a nurse team lead. Shifts are typically 8:30 to 5 or 11:30 to 8 Eastern time, with flexibility requested for occasional Saturday coverage, so this is structured shift work rather than fully self-scheduled. Beyond clinical roles the company hires the technology, product, data, actuarial, operations, and commercial staff a value-based care organisation needs, given it manages oncology spend under risk-bearing contracts. Two constraints are firm. These are licensed positions, so a current and unencumbered US registered nurse licence, or the equivalent social work credential, is a hard requirement, frequently with oncology experience expected. And between US licensure and the Eastern-time shift pattern, this is remote within the United States rather than globally remote. Listings appear on Remotive, AlleyCorp's job board, Indeed, and Glassdoor as well as the company's own careers page. Note that one aggregator lists a complex navigator role at $196,000 to $230,000, which sits far above the rest of the band for this category and should be treated with caution rather than taken as typical.

Leadership

B

Brad Diephuis

Chief Executive Officer

Became CEO in July 2026, having previously served as Thyme Care's President and Chief Operating Officer, taking over from co-founder Robin Shah as the company passed a $2B valuation.

R

Robin Shah

Co-Founder & Executive Chairman, Thyme Companies

Co-founded Thyme Care in 2020 and led it as CEO until July 2026, growing it to serve 270,000+ people and manage over $7B in oncology spend. Now Executive Chairman of Thyme Companies.

B

Bobby Green

Co-Founder & Chief Medical Officer

Co-founded Thyme Care and serves as Chief Medical Officer, a practising oncologist shaping its clinical model for navigation and value-based cancer care.

Hiring process

  1. 1

    Apply via thymecare.com careers

    Remote clinical roles including oncology nurse navigator, transitions of care nurse, and social work positions. Listings also appear on Remotive, AlleyCorp, Indeed and Glassdoor.

  2. 2

    Licensure check

    A current unencumbered US RN licence or equivalent social work credential is a hard requirement, often with oncology experience expected. Confirm which states your licence covers.

    About 5 days

  3. 3

    Recruiter screen

    Covers role fit, oncology background, and confirmation you can work the shift pattern, typically 8:30 to 5 or 11:30 to 8 Eastern with occasional Saturday cover.

    About 7 days

  4. 4

    Clinical interviews

    Assessment of clinical judgment in triage and symptom management, plus the communication skills needed to support patients and families by phone and video.

    About 10 days

  5. 5

    Offer

    Offer at the published rate for the role. Clarify shift assignment, weekend expectations, and any multi-state licensure requirements.

    About 7 days

Funding

StageSeries C+
Total raised$400,000,000
Investors
CVS Health Ventures Humana Morgan Health a16z Bio + Health Foresite Capital Town Hall Ventures AlleyCorp Concord Health Partners Frist Cressey Ventures Memorial Hermann Health System Texas Oncology

Awards & recognition

  • Raised $125M at a valuation above $2 billion · 2026

    CNBC

  • Reached profitability alongside its $97M Series D · 2025

    Thyme Care

  • Services available to 10.5M+ people across all 50 US states · 2026

    Thyme Care

Company information

  • Industry: Value-Based Oncology / Cancer Care Navigation
  • Location: Nashville, TN, USA (clinical roles remote, US-only, Eastern-time shifts)
  • Founded: 2020
  • Employees: 400
  • Website: www.thymecare.com ↗
  • LinkedIn: Company page ↗

Frequently asked questions

What does Thyme Care do?
It provides value-based cancer care navigation, using nurse navigators, social workers and care partners to support people through a cancer diagnosis with triage, symptom management, education, transitions of care and psychosocial support, working with oncologists and health plans under value-based contracts. It manages over $7B in oncology spend.
Are Thyme Care jobs remote?
Yes for its clinical navigation roles, which are remote within the United States. Note the shift structure is typically 8:30 to 5 or 11:30 to 8 Eastern time with occasional Saturday cover, so it is structured shift work rather than flexible self-scheduling.
What does Thyme Care pay?
It publishes rates on listings, which is unusual for clinical hiring: Oncology Nurse Navigator $39.90/hour, Oncology Transitions of Care Nurse $45.67/hour, Oncology Nurse Team Lead around $104,000, and Social Work Team Lead around $105,000.
Do I need a nursing licence?
For the clinical roles, yes. A current unencumbered US registered nurse licence or the equivalent social work credential is a hard requirement, frequently with oncology experience expected. That also makes these roles US-only rather than globally remote.
Who runs Thyme Care?
Brad Diephuis has been CEO since July 2026, having previously been President and COO. Co-founder Robin Shah, who led the company from 2020, is now Executive Chairman of Thyme Companies. Co-founder Bobby Green is Chief Medical Officer. Older sources still naming Shah as CEO are out of date.
How is Thyme Care funded?
It has raised roughly $400 million in total. A $97M Series D in September 2025 took it to $275M raised, past a $1B valuation, and came as it reported reaching profitability. A further $125M in September 2026 lifted its valuation above $2 billion. Investors include CVS Health Ventures, Humana, Morgan Health, a16z Bio + Health, Foresite Capital, Town Hall Ventures and AlleyCorp.

Stay in the loop.

One email per week, 5 hand-picked roles.